Sir Pangalos is a distinguished biopharmaceutical executive who led BioPharmaceuticals R&D at...
Preclinical data support profile for development of a potential best-in-class drug IND submission expected in...
VANCOUVER, Wash. and NEW YORK, Jan. 03, 2024 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a...
VANCOUVER, Wash. and NEW YORK, Dec. 28, 2023 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a...
Leading AI biologics and precision medicine innovators will harness technologies to build a diverse portfolio...
By Chris Wack Absci shares were up 27% at $2.21 after the company entered into a collaboration with AstraZeneca to deliver an AI-designed antibody...
VANCOUVER, Wash., Dec. 04, 2023 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a leader in generative...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.